羟乙基淀粉(200/0.5)氯化钠注射液 注射剂(大容量注射剂) 500ml:羟乙基淀粉(200/0.5)30g与氯化钠4.5g Китай - китайский - CFDA (药监局 - 中国食品和药物管理局)

羟乙基淀粉(200/0.5)氯化钠注射液 注射剂(大容量注射剂) 500ml:羟乙基淀粉(200/0.5)30g与氯化钠4.5g

华润双鹤药业股份有限公司 - 注射剂(大容量注射剂) - 500ml:羟乙基淀粉(200/0.5)30g与氯化钠4.5g

特慕血舒 6% 靜脈輸注液 Тайвань - китайский - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

特慕血舒 6% 靜脈輸注液

台灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - poly(o-2- hydroxyethyl)starch (hes)(molar subs 0.42; average molecular weight 130000 da);;sodium chloride;;potassium chloride;;calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;sodium acetate trihydrate (eq to sodium acetate 3h2o );;malic acid - 注射液劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) mg; potassium chloride (4012001800) mg; sodium chloride (4012002100) mg; poly(o-2- hydroxyethyl)starch (hes)(molar subs 0.42; average molecular weight 130000 da) (9600009069) mg; malic acid (9600017800) mg - blood substitutes and plasma protein fractions - 單獨使用晶質輸注液無法治療之急性出血導致之低血容積病人，本品無法取代紅血球及血漿中的凝血因子。

赫適注射液 Тайвань - китайский - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

赫適注射液

信東生技股份有限公司 桃園市桃園區介壽路２２號 (43211700) - sodium chloride;;hydroxyethyl starch (200/0.5) - 注射劑 - sodium chloride (4012002100) 9mg; hydroxyethyl starch (200/0.5) (9600009067) 60mg - blood substitutes and plasma protein fractions - 單獨使用晶質輸注液無法治療之急性出血導致之低血容積病人，本品無法取代紅血球及血漿中的凝血因子

TRICITRASOL- trisodium citrate dihydrate solution Соединенные Штаты - английский - NLM (National Library of Medicine)

tricitrasol- trisodium citrate dihydrate solution

citra labs llc - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anhydrous citric acid 14 g in 30 ml - tricitrasol ® anticoagulant sodium citrate concentrate, 46.7% trisodium citrate, is an anticoagulant used in granulocytapheresis procedures (granulocyte collection by apheresis). just prior to performing granulocytapheresis, aseptically add 30 ml of tricitrasol ® to 500 ml of the 6% solution of hydroxyethyl starch (hes), e.g. hespan ® 2-8 . agitate the resultant solution for 1 minute to assure a uniform concentration of anticoagulant. the resultant solution of tricitrasol ® and 6% solution of hes contains the following concentration depending upon the volume used: the tricitrasol ® /hes solution is stable for up to 24 hours at room temperature after mixing. refer to the manufacturer's operator's manual of the apheresis medical device for the directions to perform the granulocytapheresis procedure. not for direct intravenous infusion.

Voluhes 60 mg/9 mg per mL (6 g/900 mg per 100 mL) (6%w/v/0.9%w/v) Solution for Injection (IV Infusion) Филиппины - английский - FDA (Food And Drug Administration)

voluhes 60 mg/9 mg per ml (6 g/900 mg per 100 ml) (6%w/v/0.9%w/v) solution for injection (iv infusion)

medinova pharmaceutical, inc. - hydroxyethyl starch , sodium chloride - solution for injection (iv infusion) - 60 mg/9 mg per ml (6 g/900 mg per 100 ml) (6%w/v/0.9%w/v)

Genstarch 60 mg/9 mg per mL (6 g/900 mg per 100 mL) (6% w/v/0.9% w/v) Solution for Injection (IV Infusion) Филиппины - английский - FDA (Food And Drug Administration)

genstarch 60 mg/9 mg per ml (6 g/900 mg per 100 ml) (6% w/v/0.9% w/v) solution for injection (iv infusion)

n/a; importer: medinova pharmaceutical inc; distributor: ga2 pharmaceutical inc. - hydroxyethyl starch , sodium chloride - solution for injection (iv infusion) - 60 mg/9 mg per ml (6 g/900 mg per 100 ml) (6% w/v/0.9% w/v)

HES-130 15 g/ 2.25 g (130/0.4) per 250 mL Solution for Injection (IV) Филиппины - английский - FDA (Food And Drug Administration)

hes-130 15 g/ 2.25 g (130/0.4) per 250 ml solution for injection (iv)

endure medical, inc.; distributor: endure medical, inc. - hydroxyethyl starch 130/0.4, sodium chloride - solution for injection (iv) - 15 g/ 2.25 g (130/0.4) per 250 ml

Pentastarch 100 mg/ml Infusionsvätska, lösning Швеция - шведский - Läkemedelsverket (Medical Products Agency)

pentastarch 100 mg/ml infusionsvätska, lösning

baxter medical ab - hydroxietylstärkelse, 200/0,5; natriumklorid - infusionsvätska, lösning - 100 mg/ml - natriumklorid 9 g aktiv substans; hydroxietylstärkelse, 200/0,5 100 g aktiv substans - polyhydroxietylstärkelse

Pentastarch 60 mg/ml Infusionsvätska, lösning Швеция - шведский - Läkemedelsverket (Medical Products Agency)

pentastarch 60 mg/ml infusionsvätska, lösning

baxter medical ab - hydroxietylstärkelse, 200/0,5; natriumklorid - infusionsvätska, lösning - 60 mg/ml - hydroxietylstärkelse, 200/0,5 60 g aktiv substans; natriumklorid 9 g aktiv substans - polyhydroxietylstärkelse

Tetraspan 6 % Infusionslösung Германия - немецкий - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

tetraspan 6 % infusionslösung

b. braun melsungen aktiengesellschaft (3049484) - hydroxyethylstärke (ph.eur.) ((mit weiteren angaben: mittlere relative molmasse; molare substitution (ms) oder substitutionsgrad (ds); c2/c6-ethoxylierungsverhältnis; herkunft der stärke)); natriumchlorid; kaliumchlorid; calciumchlorid-dihydrat; magnesiumchlorid-hexahydrat; natriumacetat-trihydrat; Äpfelsäure o.w.a. - infusionslösung - hydroxyethylstärke (ph.eur.) ((mit weiteren angaben: mittlere relative molmasse; molare substitution (ms) oder substitutionsgrad (ds); c2/c6-ethoxylierungsverhältnis; herkunft der stärke)) (09611) 60 gramm; natriumchlorid (00211) 6,25 gramm; kaliumchlorid (00163) 0,3 gramm; calciumchlorid-dihydrat (00059) 0,37 gramm; magnesiumchlorid-hexahydrat (01042) 0,2 gramm; natriumacetat-trihydrat (01615) 3,27 gramm; Äpfelsäure o.w.a. (08161) 0,67 gramm